Prognostic markers of pediatric meningococcal sepsis

References

• Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2012;41:580-637
   Web of Science ®Google Scholar
• Briassoulis G, Kalabalikis P, Thanopoulos V, et al. Non-Q wave acute myocardial infarction in acute meningococcemia in a 10-year-old girl. Pediatr Emerg Care 2000;16(1):33-8
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50
   PubMed Web of Science ®Google Scholar
• Bratcher HB, Bennett JS, Maiden MC. Evolutionary and genomic insights into meningococcal biology. Future Microbiol 2012;7(7):873-85
   PubMed Web of Science ®Google Scholar
• Wong HR, Weiss SL, Giuliano JS Jr, et al. The temporal version of the pediatric sepsis biomarker risk model. PLoS One 2014;9(3):e92121
   PubMed Web of Science ®Google Scholar
• van Well GT, Sanders MS, Ouburg S, et al. Single nucleotide polymorphisms in pathogen recognition receptor genes are associated with susceptibility to meningococcal meningitis in a pediatric cohort. PLoS One 2013;8(5):e64252
   PubMed Web of Science ®Google Scholar
• Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369(21):2063
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Briassouli E, Fitrolaki DM, et al. Heat shock protein 72 expressing stress in sepsis: unbridgeable gap between animal and human studies – a hypothetical “comparative” study. Biomed Res Int 2014;2014:101023
   PubMed Web of Science ®Google Scholar
• Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 2011;6(3):273-83
   PubMed Web of Science ®Google Scholar
• Hao W, Ma JH, Warren K, et al. Extensive genomic variation within clonal complexes of Neisseria meningitidis. Genome Biol Evol 2011;3:1406-18
   PubMed Web of Science ®Google Scholar
• Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008;178(3):276-82
   PubMed Web of Science ®Google Scholar
• Van der Kaay DC, De Kleijn ED, De Rijke YB, et al. Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 2002;8(11):1606-12
   Web of Science ®Google Scholar
• Hatherill M, Tibby SM, Turner C, et al. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000;28(7):2591-4
   PubMed Web of Science ®Google Scholar
• Sprong T, van der Ven-Jongekrijg J, Neeleman C, et al. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease. Crit Care Med 2009;37(10):2812-18
   PubMed Web of Science ®Google Scholar
• Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345(6):408-16
   PubMed Web of Science ®Google Scholar
• Binder A, Endler G, Rieger S, et al. Central European Meningococcal Genetic Study Group. Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia. Hum Genet 2007;122(2):183-90
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Narlioglou M, ZavrasN, Hatzis T. Myocardial injury in meningococcus-induced purpura fulminans in children. Intensive Care Med 2001;27(6):1073-82
   PubMed Web of Science ®Google Scholar
• Marshall JC. Sepsis: rethinking the approach to clinical research. J Leukoc Biol 2008;83(3):471-82
   PubMed Web of Science ®Google Scholar
• Paize F, Sarginson R, Makwana N, et al. Changes in the sublingual microcirculation and endothelial adhesion molecules during the course of severe meningococcal disease treated in the paediatric intensive care unit. Intensive Care Med 2012;38(5):863-71
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Papassotiriou I, Mavrikiou M, et al. Longitudinal course and clinical significance of TGF-beta1, sL- and sE-Selectins and sICAM-1 levels during severe acute stress in children. Clin Biochem 2007;40(5-6):299-304
   PubMed Web of Science ®Google Scholar
• van der Flier M, Sharma DB, Estevão S, et al. Increased CD4(+) T cell co-inhibitory immune receptor CEACAM1 in neonatal sepsis and soluble-CEACAM1 in meningococcal sepsis: a role in sepsis-associated immune suppression? PLoS One 2013;8(7):e68294
   PubMed Web of Science ®Google Scholar
• Carrol ED, Newland P, Thomson APJ, et al. Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med 2005;33(1):224-5
   PubMed Web of Science ®Google Scholar
• van Waardenburg DA, Jansen TC, Vos GD, et al. Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab 2006;91:3916-21
   PubMed Web of Science ®Google Scholar
• Fitrolaki DM, Dimitriou H, Kalmanti M, et al. CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMC Pediatr 2013;13:31
   PubMed Web of Science ®Google Scholar
• Marino LV, Pathan N, Meyer R, et al. Glutamine depletion and heat shock protein 70 (HSP70) in children with meningococcal disease. Clin Nutr 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Briassouli E, Goukos D, Daikos G, et al. Glutamine suppresses Hsp72 not Hsp90a and is not inducing Th1, Th2, or Th17. Nutrition 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• van der Pol WL, Huizinga TW, Vidarsson G, et al. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis 2001;184(12):1548-55
   PubMed Web of Science ®Google Scholar
• Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther 2011;9(1):71-9
   PubMed Web of Science ®Google Scholar
• Kwan A, Hubank M, Rashid A, et al. Transcriptional instability during evolving sepsis may limit biomarker based risk stratification. PLoS One 2013;8(3):e60501 3
   PubMed Web of Science ®Google Scholar